Suzanne Carlberg-Racich, MSPH, PHD

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

CDC-NIMH Conference Closing Meditations Thomas J. Coates PhD Professor of Medicine Director, AIDS Research Institute University of California San Francisco.
Models of Harm Reduction
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Medical Director Jackson County Health and Human Services
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Peterborough Drug Strategy
Recommendations on the Management of Opioid Overdose Ruth Birgin.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Building Trust With the Injection Drug Community Megan Hatta, RN.
Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
SAFE PLACES GAME. With safe injection sites would there be an increased use of addiction treatment? The SIF's opening was associated independently with.
Abuse-Deterrent Opioids: FDA’s Role and Emerging Challenges Jeanne Ireland Principal, Ireland Strategies, LLC 2015 CWAG Annual Meeting.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
Pharmacist Role in Naloxone Prescribing
MODULE 3 Harm reduction advocacy
The Highs and Lows of Relapse and Recovery in Opioid Use Disorder
State Targeted Response to Opioid Crisis
Rhetoric vs. Reality: The Politics of Addiction Treatment Reform
Missouri Network for Opiate Reform and Recovery
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Fear of Economic Ramifications
Understanding a Harm Reduction Approach to Drug Interventions
Integrating Care Through Partnerships – Missouri’s Experience
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Nebraska Prescription Drug Overdose Prevention Program Efforts
Hepatitis C Allies of Philadelphia August 2, 2017
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
COLLECTIVE IMPACT APPROACH TO ADDRESSING
An overdose Reduction PlaN
The Efficacy of RN Supervised Safe Injection Sites
McLean Hospital Division of Alcohol and Drug Abuse
The Impact of Market Based Healthcare on the Opioid Epidemic
Addressing Drug Use Together Through a Health Based Approach:
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
Opioid Crisis A Call to ACTION
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Stigma and Substance Use Disorders (SUDs)
Steve Alsum The Grand Rapids Red Project
Jonathan Mermin, MD, MPH RADM, USPHS
A State Targeted Response to the Opioid Crisis:
Community Researcher?? Patient Researcher?? Patient Researcher??
Head of Research centre
Towards a Conducive Legal and Structural Environment
Methadone Scenario 3 Based on Stigma & Trust Findings from the
Opioids in Butte County
Review why we’re doing this work Display survey results
Opioid-related harms and responses
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
The HIV Epidemic among People who Inject Drugs
Pain Management and Substance Use Disorders: JCPP Strategic Session
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Using Data to Combat the Opioid Overdose Crisis
Ten Pearls for Medication Assisted Treatment of Opiate Use Disorders
How Can Students Get Involved in Prescription Education and Awareness?
buprenorphine-naloxone
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
a Supervised consumption site for Barrie
No conflicts of interest
Strategic Initiatives to Address Opioid Overdose & Addiction
Human Dignity and Harm Reduction
Medically assisted treatment
Presentation transcript:

Reframing the Rhetoric: Using evidence in reporting about substance use Suzanne Carlberg-Racich, MSPH, PHD Board Member, Health & Medicine Policy Research Group Assistant Professor of Public Health, DePaul University Director of Research, Chicago Recovery Alliance

Opioid Overdose Deaths, 2015 and 2016 The death rate from opioid overdose increased 74% in one year in Chicago. Age-adjusted death rate per 100,000 Slide courtesy of Dr. Elizabeth Salisbury-Afshar, American Institutes for Research Seth P, et al. Overdose Deaths Involving Opioids, Cocaine and Psychostimulants- US 2015-2016. MMWR March 30, 2018. Epidemiology Report: Increase in Overdose Deaths Involving Opioids, Chicago 2015-2016

Opioid-Related Overdose Deaths by Drug Type in Chicago, 2015 and 2016 Age-adjusted death rate per 100,000 Slide courtesy of Dr. Elizabeth Salisbury-Afshar, American Institutes for Research Epidemiology Report: Increase in Overdose Deaths Involving Opioids, Chicago 2015-2016

Opioid Overdose Death Rate by Age in the United States Opioid Overdose Death Rate by Age in the United States* and Chicago, 2016 Age-adjusted death rate per 100,000 Age range in years * Includes 31 states and the District of Columbia Slide courtesy of Dr. Elizabeth Salisbury-Afshar, American Institutes for Research Scholl L, Seth P, et al. Drug and Opioid-Involved Overdose Deaths- United States, 2013-2017. MMWR Jan 4 2018;67(5152);1419-1427 Epidemiology Report: Increase in Overdose Deaths Involving Opioids, Chicago 2015-2016

Opioid Overdose Death Rate by Gender in the United States Opioid Overdose Death Rate by Gender in the United States* and Chicago, 2016 Age-adjusted death rate per 100,000 * Includes 31 states and the District of Columbia Slide courtesy of Dr. Elizabeth Salisbury-Afshar, American Institutes for Research Scholl L, Seth P, et al. Drug and Opioid-Involved Overdose Deaths- United States, 2013-2017. MMWR Jan 4 2018;67(5152);1419-1427 Epidemiology Report: Increase in Overdose Deaths Involving Opioids, Chicago 2015-2016

Opioid Overdose Death Rate by Race/Ethnicity in the United States Opioid Overdose Death Rate by Race/Ethnicity in the United States* and Chicago, 2016 Age-adjusted death rate per 100,000 * Includes 31 states and the District of Columbia Slide courtesy of Dr. Elizabeth Salisbury-Afshar, American Institutes for Research Scholl L, Seth P, et al. Drug and Opioid-Involved Overdose Deaths- United States, 2013-2017. MMWR Jan 4 2018;67(5152);1419-1427 Epidemiology Report: Increase in Overdose Deaths Involving Opioids, Chicago 2015-2016

It starts to feel like I’m a prisoner, but literally and figuratively… I feel like there are so many factors that contribute to my story, but to open up means to incriminate myself, so being a user is a lonely life. I feel like a menace to society sometimes because people look at it that way.

The personal impact of stigma I feel like I’m marked. Because I inject drugs, it’s as if I’m contagious. People don’t want to get to know me or get too close. As a result, I feel like the lowest form of life, forced to live off of what others throw away. I’m not good enough to fully indulge in all that being part of a community entails.

The outcomes of stigma PWID experience pervasive, ongoing stigma (Chang, Dubbin & Shim, 2015) This stigma is associated with poorer health outcomes (Chang, Dubbin & Shim, 2015) PWID are less likely to access medical, mental health, and social services (Treloar, Rance & Backmund, 2013) Fear of arrest perpetuates unsafe practices, increases in HIV infection risk1-4, and discarded litter. Negative health outcomes often occur in these spaces5. 1. Kerr et al., 2005; 2. Maher & Dixon D., 1999; 3. Werb et al. 2016; 4. Kerr et al. 2015; 5. Sherman, S., et al. A Report for the Abell Foundation

The Importance of Scientific Sources

The importance of imaging This is how I’m viewed by the people I’m talking to. This is how I perceive you perceiving me. This isn’t my experience.

The importance of people first Bridge the Gap of Understanding! I see people misunderstanding us all the time – assuming the worst… Get to know us, learn about us, we are the same as you, just dealing with this challenge.

Public Health Approaches to the Opioid Overdose Epidemic Strategies that Dominate Strategies that Work Scare tactic-based primary prevention Safe opioid prescribing & disposal Pharmaceutical crackdowns & opioid reformulations Tough love Getting people “clean” with abstinence Law enforcement approach Comprehensive reality-based education Harm reduction Overdose Education & Naloxone Distribution Overdose Prevention Sites / Safer Consumption Spaces Opioid Agonist Therapy Decriminalization All states but MO have PDMP. Missouri passed legislation in April 2017 to adopt state PDMP. Several states have enacted legislation that will limit the number/day supply of opioids that can be prescribed (NJ, NY, MA, etc. NJ limits to 5 day supply) I detoxed, but relapsed…can't afford suboxone; we need to take money from jails and put it into treatment